Elevated serum uric acid level was a notable adverse event during combination therapy with sofosbuvir and ribavirin
Journal article published in 2017 by
Ken Sato,
Atsushi Naganuma 
,
Tamon Nagashima,
Takashi Hoshino,
Daisuke Uehara,
Yousuke Arai,
Katsuhiko Horiuchi,
Kazuhisa Yuasa,
Hisashi Takayama,
Hirotaka Arai,
Takeshi Hatanaka,
Tatsuya Ohyama,
Hiroki Tahara,
Naondo Sohara,
Takeshi Kobayashi
and other authors.
,
Tamon Nagashima,
Takashi Hoshino,
Daisuke Uehara,
Yousuke Arai,
Katsuhiko Horiuchi,
Kazuhisa Yuasa,
Hisashi Takayama,
Hirotaka Arai,
Takeshi Hatanaka,
Tatsuya Ohyama,
Hiroki Tahara,
Naondo Sohara,
Takeshi Kobayashi
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 